| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 08.02.
| Sequenom CMM's MaterniT21' PLUS Test Expands Current Prenatal Testing Offering | | 32 | PR Newswire |
| SAN DIEGO, Feb. 8, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly-owned...
Mehr lesen zu:
Sequenom CMM's MaterniT21' PLUS Test Expands Current Prenatal Testing Offering | |
| 06.02.
| Sequenom Shares Climbing Higher, Up 12.5% | | 7 | SmarTrend |
| 02.02.
| Sequenom Announces Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies | | 7 | Benzinga.com |
| 02.02.
| Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies | | 17 | PR Newswire |
| SAN DIEGO, Feb.2, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that a new publication of an independent...
Mehr lesen zu:
Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies | |
| 27.01.
| Has Sequenom Become the Perfect Stock? | | 23 | Motley Fool |
| 26.01.
| Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock | | 9 | PR Newswire |
| SAN DIEGO, Jan. 25, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced the completion of an underwritten public offering of 14,950,000 shares of its common stock, including...
Mehr lesen zu:
Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock | |
| 25.01.
| Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock | | - | Benzinga.com |
| 25.01.
| Sequenom (SQNM) Completes 14.95M Offering; Underwriters Exercise Full Overallotment | | - | StreetInsider.com |
| 25.01.
| Sequenom CEO Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript) | | - | Seeking Alpha |
| 21.01.
| 2 Positive Signs for Sequenom | | 12 | Motley Fool |
| 20.01.
| Sequenom Down 6.3%, Shares Slide into the Red | | 4 | SmarTrend |
| 20.01.
| Sequenom Prices Public Offering Of 13 Mln Shares At $4.15/shr | | 35 | AFX News |
| WASHINGTON (dpa-AFX) - Sequenom Inc. (SQNM) announced the pricing of an
underwritten public offering of 13 million shares of its common stock, offered
at a price to the public of $4.15 per...
Mehr lesen zu:
Sequenom Prices Public Offering Of 13 Mln Shares At $4.15/shr | |
| 20.01.
| Sequenom (SQNM) Prices 13M Offering at $4.15/Share | | 3 | StreetInsider.com |
| 20.01.
| Sequenom Prices Public Offering of Common Stock | | 24 | PR Newswire |
| SAN DIEGO, Jan. 20, 2012 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock, offered...
Mehr lesen zu:
Sequenom Prices Public Offering of Common Stock | |
| 19.01.
| Sequenom Announces Proposed Public Offering of Common Stock | | 17 | PR Newswire |
| SAN DIEGO, Jan.19, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock...
Mehr lesen zu:
Sequenom Announces Proposed Public Offering of Common Stock | |
| 12.01.
| Watch Sequenom (SQNM) Shares as Presentation Begins at JPMorgan Healthcare Conference | | 2 | StreetInsider.com |
| 11.01.
| Sequenom (SQNM) Named as Defendant in Pre-Natal Paternity Test Case | | 6 | StreetInsider.com |
| 09.01.
| Sequenom (SQNM) Sees 2011 Rev Growth of 23% | | 6 | StreetInsider.com |
| 09.01.
| Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook | | 64 | PR Newswire |
| SAN DIEGO, Jan. 8, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company's 2011 performance...
Mehr lesen zu:
Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook | |
| 05.01.
| Sequenom Announces Participation at the 30th Annual J.P. Morgan Healthcare Conference | | 40 | PR Newswire |
| SAN DIEGO, Jan. 5, 2012 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation...
Mehr lesen zu:
Sequenom Announces Participation at the 30th Annual J.P. Morgan Healthcare Conference | |
